DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication
Contribución de congreso (ConferenceOutput)
Tailoring chemical tools for modulating the Kv4.3/KChIP3 interaction
Resumen del trabajo presentado al VI Meeting de la Red Española de Canales Ióniocs (RECI), celebrado en Santiago de Compostela del 6 al 8 de septiembre de 2017., KChIP-3 (potassium channel interacting protein-3), also known as DREAM (Downstream Regulatory Element Antagonist Modulator) or calsenilin, is a multifunctional calcium binding protein that controls the expression level and/or the activity of several proteins related to calcium homeostasis, neuronal excitability and neuronal survival.1 As an auxiliary protein in the plasma membrane, KChIP-3 interacts with, and regulates, among others, the gating of KV4 potassium channels, L- and T-type voltage-dependent calcium channels, NMDA receptors and the transcriptor factor ATF6, which is involved in the unfolding protein response machinery. Considering that altered neuronal calcium homeostasis and the accumulation of poorly folded proteins are common features of many neurodegenerative pathologies, the KChIP-3 modulation could open new avenues for the treatment of different neurodegenerative diseases. However, up to now, only three KChIP-3 binding molecules have been identified. Hence, there is a clear need for the development of chemical tools to modulate and characterize KChIP-3 activity and its interactions. In this communication we report the rational design and synthesis of new KChIP-3 ligands as pharmacological tools to study its protein-protein interaction network, focusing on those interactions involved in neurodegenerative pathologies., This work was supported by Ministerio de Economia y Competitividad (BFU2015-67284-R) and CSIC (201580E073-PIE)., Peer Reviewed